000 | 02871 a2200865 4500 | ||
---|---|---|---|
005 | 20250517215427.0 | ||
264 | 0 | _c20190409 | |
008 | 201904s 0 0 eng d | ||
022 | _a1474-5488 | ||
024 | 7 |
_a10.1016/S1470-2045(18)30204-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRobinson, Giles W | |
245 | 0 | 0 |
_aRisk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. _h[electronic resource] |
260 |
_bThe Lancet. Oncology _c06 2018 |
||
300 |
_a768-784 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aAustralia |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCerebellar Neoplasms _xgenetics |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Decision-Making |
650 | 0 | 4 |
_aCranial Irradiation _xadverse effects |
650 | 0 | 4 | _aDNA Methylation |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMedulloblastoma _xgenetics |
650 | 0 | 4 |
_aNeoadjuvant Therapy _xadverse effects |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aProgression-Free Survival |
650 | 0 | 4 | _aRadiation Dosage |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aRudneva, Vasilisa A | |
700 | 1 | _aBuchhalter, Ivo | |
700 | 1 | _aBillups, Catherine A | |
700 | 1 | _aWaszak, Sebastian M | |
700 | 1 | _aSmith, Kyle S | |
700 | 1 | _aBowers, Daniel C | |
700 | 1 | _aBendel, Anne | |
700 | 1 | _aFisher, Paul G | |
700 | 1 | _aPartap, Sonia | |
700 | 1 | _aCrawford, John R | |
700 | 1 | _aHassall, Tim | |
700 | 1 | _aIndelicato, Daniel J | |
700 | 1 | _aBoop, Frederick | |
700 | 1 | _aKlimo, Paul | |
700 | 1 | _aSabin, Noah D | |
700 | 1 | _aPatay, Zoltan | |
700 | 1 | _aMerchant, Thomas E | |
700 | 1 | _aStewart, Clinton F | |
700 | 1 | _aOrr, Brent A | |
700 | 1 | _aKorbel, Jan O | |
700 | 1 | _aJones, David T W | |
700 | 1 | _aSharma, Tanvi | |
700 | 1 | _aLichter, Peter | |
700 | 1 | _aKool, Marcel | |
700 | 1 | _aKorshunov, Andrey | |
700 | 1 | _aPfister, Stefan M | |
700 | 1 | _aGilbertson, Richard J | |
700 | 1 | _aSanders, Robert P | |
700 | 1 | _aOnar-Thomas, Arzu | |
700 | 1 | _aEllison, David W | |
700 | 1 | _aGajjar, Amar | |
700 | 1 | _aNorthcott, Paul A | |
773 | 0 |
_tThe Lancet. Oncology _gvol. 19 _gno. 6 _gp. 768-784 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(18)30204-3 _zAvailable from publisher's website |
999 |
_c28408358 _d28408358 |